Experimental therapy for parasitic heart disease may also help stop COVID-19
Cardiovascular risk factors tied to poor pregnancy outcomes
2 April 2021Study sheds light on interplay among PTSD, combat experience, alcohol use
2 April 2021Experimental therapy for parasitic heart disease may also help stop COVID-19
James McKerrow, MD, Ph.D., dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has long studied neglected tropical diseases—chronic and disabling parasitic infections that primarily affect poor and underserved communities in developing nations. They’re called “neglected” because there is little financial incentive for pharmaceutical companies to develop therapies for them.
